Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab
======================================================================================================================================================

* Yoshinobu Koguchi
* Noriko Iwamoto
* Takashi Shimada
* Shu-Ching Chang
* John Cha
* Brendan D Curti
* Walter J Urba
* Brian D Piening
* William L Redmond